Shivansh Luthra

Amritsar, PB, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System.

Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System.

Journal: Cureus
Published: July 25, 2026

Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026).

Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026).

Journal: Cureus
Published: July 24, 2026

Fabry Disease in a Female: A Unique Case Highlighting the Variability in Clinical Presentation.

Fabry Disease in a Female: A Unique Case Highlighting the Variability in Clinical Presentation.

Journal: Cureus
Published: September 28, 2024

Effect of Zinc Supplementation on Glycemic Control in Newly Diagnosed Patients With Type 2 Diabetes Mellitus.

Effect of Zinc Supplementation on Glycemic Control in Newly Diagnosed Patients With Type 2 Diabetes Mellitus.

Journal: Cureus
Published: September 11, 2024

Evolving Radiological Approaches in the Diagnosis and Monitoring of Arachnoiditis Ossificans.

Evolving Radiological Approaches in the Diagnosis and Monitoring of Arachnoiditis Ossificans.

Journal: Cureus
Published: August 31, 2024

Gastroesophageal Reflux Disease: New Insights and Treatment Approaches.

Gastroesophageal Reflux Disease: New Insights and Treatment Approaches.

Journal: Cureus
Published: August 23, 2024

Decoding Cancer Risk: Understanding Gene-Environment Interactions in Cancer Development.

Decoding Cancer Risk: Understanding Gene-Environment Interactions in Cancer Development.

Journal: Cureus
Published: July 17, 2024

Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health.

Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health.

Journal: Cureus
Published: July 17, 2024
Showing 1-8 of 8

Last Updated: 09/26/2026